A significant breakthrough in cancer study is occurring with the use of nanobodies to re-engage mutated p53. This crucial malignant suppressor protein is frequently disabled in various forms of malignancies, causing https://extrabookmarking.com/story21948465/mini-antibodies-reactivate-tumor-suppressor-p53-the-potential-hope-for-cancer-management